These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33753411)
1. Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway. Ao X; Yang Y; Okiji T; Azuma M; Nagai S Infect Immun; 2021 May; 89(6):. PubMed ID: 33753411 [TBL] [Abstract][Full Text] [Related]
2. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis. Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ Front Immunol; 2020; 11():1299. PubMed ID: 32719675 [No Abstract] [Full Text] [Related]
3. Enhanced expression of PD-L1 in oral squamous cell carcinoma-derived CD11b(+)Gr-1(+) cells and its contribution to immunosuppressive activity. Fuse H; Tomihara K; Heshiki W; Yamazaki M; Akyu-Takei R; Tachinami H; Furukawa KI; Sakurai K; Rouwan M; Noguchi M Oral Oncol; 2016 Aug; 59():20-29. PubMed ID: 27424179 [TBL] [Abstract][Full Text] [Related]
4. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation. Li W; Tu J; Liu X; Yang W Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912 [TBL] [Abstract][Full Text] [Related]
5. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673 [TBL] [Abstract][Full Text] [Related]
6. Spleen-derived IFN-γ induces generation of PD-L1 Langereis JD; Pickkers P; de Kleijn S; Gerretsen J; de Jonge MI; Kox M J Leukoc Biol; 2017 Dec; 102(6):1401-1409. PubMed ID: 28974543 [TBL] [Abstract][Full Text] [Related]
7. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors. Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045 [TBL] [Abstract][Full Text] [Related]
8. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246 [TBL] [Abstract][Full Text] [Related]
9. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680 [TBL] [Abstract][Full Text] [Related]
10. Identification of B7-H1 as a novel mediator of the innate immune/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis. Huang X; Chen Y; Chung CS; Yuan Z; Monaghan SF; Wang F; Ayala A J Immunol; 2014 Feb; 192(3):1091-9. PubMed ID: 24379123 [TBL] [Abstract][Full Text] [Related]
11. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1. Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099 [TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibition Followed by Tumor Infiltration of Dendritic Cells in Murine Neuro-2a Neuroblastoma. Inoue S; Horiuchi Y; Setoyama Y; Takeuchi Y; Beck Y; Murakami T; Odaka A J Surg Res; 2020 Sep; 253():201-213. PubMed ID: 32380346 [TBL] [Abstract][Full Text] [Related]
13. [Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression]. Xu Y; Zang X; Chen W Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):332-336. PubMed ID: 38538366 [TBL] [Abstract][Full Text] [Related]
14. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy. Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036 [TBL] [Abstract][Full Text] [Related]
15. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy. Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH Front Immunol; 2021; 12():654463. PubMed ID: 34054817 [TBL] [Abstract][Full Text] [Related]
16. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation. van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658 [TBL] [Abstract][Full Text] [Related]
17. Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function. Landoni VI; Martire-Greco D; Rodriguez-Rodrigues N; Chiarella P; Schierloh P; Isturiz MA; Fernández GC Clin Sci (Lond); 2016 Feb; 130(4):259-71. PubMed ID: 26582821 [TBL] [Abstract][Full Text] [Related]
18. Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. Christiansson L; Söderlund S; Svensson E; Mustjoki S; Bengtsson M; Simonsson B; Olsson-Strömberg U; Loskog AS PLoS One; 2013; 8(1):e55818. PubMed ID: 23383287 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells. Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828 [TBL] [Abstract][Full Text] [Related]
20. Splenectomy provides protective effects against CLP-induced sepsis by reducing TRegs and PD-1/PD-L1 expression. Chen H; Huang N; Tian H; Li J; Li B; Sun J; Zhang S; Zhang C; Zhao Y; Kong G; Li Z Int J Biochem Cell Biol; 2021 Jul; 136():105970. PubMed ID: 33774183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]